glp-1 drugs microdosing Microdosing GLP-1 for Weight Loss

Ascendis Pharma A/S granted Novo Nordisk A/S exclusive global rights to its TransCon technology for the development, manufacturing, and commercialisation of Novo Nordisk products aimed at metabolic diseases, including obesity and type 2 diabetes, along with select cardiovascular applications

FOR LOW BLOOD SUGAR SOURCE: DailyMed

Dispose of used patches in household waste - do not flush or compost

Think of an epiPen - you dont actually see the needle

[DOI] [PubMed] [Google Scholar] 14.de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, et al

This has become a headwind overall for food businesses, but there are some surprising positives for the industry as well, according to Colin Guheen, co-head of the Food & Beverage group at Capital One